Left Menu
Development News Edition

China Sinopharm's coronavirus vaccine taken by about a million people in emergency use

China launched the emergency use programme in July, which so far includes three vaccine candidates for essential workers and other limited groups of people even as clinical studies have yet to be completed to prove their safety and efficacy. No serious adverse reaction has been reported from those who received the vaccine in emergency use, Sinopharm said in an article on social media WeChat, citing Chairman Liu Jingzhen from a recent media interview.

Reuters | Beijing | Updated: 19-11-2020 12:45 IST | Created: 19-11-2020 12:33 IST
China Sinopharm's coronavirus vaccine taken by about a million people in emergency use
Representative Image Image Credit: ANI

Nearly one million people have taken an experimental coronavirus vaccine developed by China National Pharmaceutical Group (Sinopharm) through the country's emergency use programme, the firm said late on Wednesday. China launched the emergency use programme in July, which so far includes three vaccine candidates for essential workers and other limited groups of people even as clinical studies have yet to be completed to prove their safety and efficacy.

No serious adverse reaction has been reported from those who received the vaccine in emergency use, Sinopharm said in an article on social media WeChat, citing Chairman Liu Jingzhen from a recent media interview. Two vaccine candidates developed by Sinopharm's subsidiary China National Biotec Group (CNBG) and third one developed by Sinovac Biotech have been used for the emergency programme.

It's unclear which vaccine Liu referred to, and Sinopharm was not immediately available to comment. Sinopharm's vaccines, which use inactivated virus unable to replicate in human cells to trigger immune responses, require two doses, clinical trial registration data showed.

The experimental vaccines are undergoing Phase 3 clinical trials overseas that have recruited nearly 60,000 people, and blood samples of more than 40,000 participants have been taken 14 days after they took the second dose, the article said citing Liu, without breaking down the numbers for each vaccine. Among construction project employees, diplomats and students who went abroad after taking Sinopharm's vaccine, no one has been infected, it added.

But experts have cautioned against using data solely from emergency use programme, without comparable results from a clinical trial-standard control group, to determine a vaccine's effectiveness.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

China: A savior for emerging markets or a poison pill?

... ...

Future of Urban Planning: Artificial Intelligence guiding the way

Advances in emerging technologies like Artificial Intelligence and Machine Learning can help us understand our cities better and derive useful insights from real-time data collected through automated models....

Videos

Latest News

JSP chief Pawan Kalyan donates Rs 30 lakhs for Ram Temple construction in Ayodhya

The Jana Sena Party JSP president Pawan Kalyan on Friday donated a sum of Rs 30 lakhs for the construction of the Ram Temple in Uttar Pradeshs Ayodhya. The JSP president handed over the cheque for the amount to the RSS leader Bharat earlier...

Another big storm, growing stronger, set to hit central Mozambique

A powerful storm nearing Mozambique is expected to intensify into a tropical cyclone on Friday, according to forecasts, dumping rain onto already swollen rivers in an area devastated by Cyclone Idai less than two years ago.Tropical Storm El...

House to deliver Trump impeachment charge on Monday, rejecting Republican push for time

The Democratic-controlled U.S. House of Representatives will deliver an impeachment charge against former President Donald Trump to the Senate on Monday, rejecting Republican Senate Minority Leader Mitch McConnells request for a delay. Sena...

Baseball's 'Hammerin' Hank' Aaron, who held career home run record, dies at 86

Baseball Hall of Famer Hank Aaron, the quiet, unassuming slugger who broke Babe Ruths supposedly unbreakable record for most home runs in a career and battled racism in the process, died on Friday, the Atlanta Braves announced. He was 86. A...

Give Feedback